ProPhase Labs, Inc. (PRPH)

ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $14.74 million as of April 25, 2025. Its market cap has decreased by -87.63% in one year.

• Market Cap: 14.74M
• Enterprise Value: 37.93M
• 1-Year Change: -87.63%
• Ranking: #4942
• Category: Nano-Cap
• Stock Price: $0.35

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $14.74M, a decrease of -83.98%. That is a compound annual growth rate of -6.70%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	14.80M	-18.23%
Dec 31, 2024	18.10M	-77.82%
Dec 29, 2023	81.60M	-47.96%
Dec 30, 2022	156.80M	41.01%
Dec 31, 2021	111.20M	4.41%
Dec 31, 2020	106.50M	367.11%
Dec 31, 2019	22.80M	-37.36%
Dec 31, 2018	36.40M	34.81%
Dec 29, 2017	27.00M	-21.05%
Dec 30, 2016	34.20M	33.59%
Dec 31, 2015	25.60M	13.27%
Dec 31, 2014	22.60M	-11.72%
Dec 31, 2013	25.60M	26.73%
Dec 31, 2012	20.20M	19.53%
Dec 30, 2011	16.90M	-3.98%
Dec 31, 2010	17.60M	-30.98%
Dec 31, 2009	25.50M	-50.58%
Dec 31, 2008	51.60M	-15.69%
Dec 31, 2007	61.20M	-15.24%
Dec 29, 2006	72.20M	-55.24%
Dec 30, 2005	161.30M	64.42%
Dec 31, 2004	98.10M	-19.85%
Dec 31, 2003	122.40M	94.29%
Dec 31, 2002	63.00M	156.10%
Dec 31, 2001	24.60M	179.55%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	772.11B
UnitedHealth Group	386.34B
Johnson & Johnson	373.52B
AbbVie	319.85B
Novo Nordisk	276.96B
Abbott Laboratories	224.52B
AstraZeneca	213.42B
Novartis AG	208.99B